Risk of cumulative toxicity after complete melanoma response with pembrolizumab

Amy Hsin-Chieh Hsieh; Sarah Faithfull; Michael P Brown

doi:10.1136/bcr-2016-218308

Article info

CASE REPORT

Risk of cumulative toxicity after complete melanoma response with pembrolizumab

Authors

Amy Hsin-Chieh Hsieh Department of Medical Oncology, Royal Adelaide Hospital, Adelaide, South Australia, Australia PubMed articles Google scholar articles
Sarah Faithfull Radiology Department, Royal Adelaide Hospital, Adelaide, South Australia, Australia PubMed articles Google scholar articles
Michael P Brown Department of Medical Oncology, Royal Adelaide Hospital, Adelaide, South Australia, Australia PubMed articles Google scholar articles

Correspondence to Dr Amy Hsin-Chieh Hsieh, hsinchiehamy.hsieh{at}sa.gov.au

View Full Text

Citation

Hsieh AH, Faithfull S, Brown MP

Risk of cumulative toxicity after complete melanoma response with pembrolizumab

Case Reports 2017;2017:bcr2016218308.

Publication history

Accepted January 20, 2017
First published February 1, 2017.

Online issue publication

August 07, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

2017 BMJ Publishing Group Ltd

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password